Dermal Cell News Volume 8.35 | Nov 14 2022

    0
    78








    2022-11-14 | DCN 8.35


    Dermal Cell News by STEMCELL Technologies
    Vol. 8.35 – 14 November, 2022
    TOP STORY

    TPP1 Promoter Mutations Cooperate with TERT Promoter Mutations to Lengthen Telomeres in Melanoma

    The ACD promoter variants increased the expression of TPP1 and functioned together with TERT to synergistically lengthen telomeres.
    [Science]

    AbstractPress Release
    DERMTEST
    PUBLICATIONSRanked by the impact factor of the journal

    Improved Pharmacodynamics of Epidermal Growth Factor via Microneedles-Based Self-Powered Transcutaneous Electrical Stimulation

    Researchers demonstrated that the electrical stimulation applied by the microneedle-based self-powered transcutaneous electrical stimulation system acted as an “adjuvant” that suppressed the reduction of epidermal growth factor by glutathione and upregulated its receptor expression in keratinocyte cells.
    [Nature Communications]

    Full Article

    Hydrogel Microtumor Arrays to Evaluate Nanotherapeutics

    Scientists tested a technique which partitioned heterogeneous cell states within a geometric pattern, where boundary regions of curvature prime the stem cell-like fraction. Using melanoma cells of different metastatic potential, the authors discovered a relationship between stem fraction and nanoparticle uptake.
    [Advanced Healthcare Materials]

    Full Article

    Efficiency and Safety of Dextran-PAMAM/siMMP-9 Complexes for Decreasing Matrix Metalloproteinase-9 Expression and Promoting Wound Healing in Diabetic Rats

    Investigators used dextran conjugated with poly(amidoamine) (Dextran-PAMAM) as a gene carrier to deliver MMP-9 targeted siRNA (siMMP-9). The prepared complexes could be endocytosed with low cytotoxicity to HaCat cells.
    [Bioconjugate Chemistry]

    Abstract

    Targeting the MITF/APAF-1 Axis As Salvage Therapy for MAPK Inhibitors in Resistant Melanoma

    Analyzing the transcriptome of MAPK inhibitor sensitive- and resistant-melanoma, scientists discovered that APAF-1 was negatively regulated by MITF in resistant tumors, identifying the MITF/APAF-1 axis as a molecular driver of MAPK inhibitor resistance.
    [Cell Reports]

    AbstractFull ArticleGraphical Abstract

    Frizzled 6 Promotes Melanoma Cell Invasion but not Proliferation by Regulating Canonical Wnt Signaling and EMT

    Investigators showed that FZD6 was overexpressed in multiple melanoma cell lines and human samples. Knockdown or knockout of FZD6 did not affect cell proliferation, but significantly reduced the invasive ability of melanoma cells.
    [Journal of Investigative Dermatology]

    Abstract

    Mast Cells Impair Melanoma Cell Homing and Metastasis by Inhibiting HMGA1 Secretion

    Mass spectrometry analysis of melanoma-mast cell co-cultures secretome showed that HMGA1 secretion by melanoma cells was significantly impaired.
    [Immunology]

    Abstract

    Necroptosis-Mediated HMGB1 Secretion of Keratinocytes as a Key Step for Inflammation Development in Contact Hypersensitivity

    MLKL-mediated necroptosis deficiency or inhibition resulted in blocking recruitment and activation of inflammatory cells in contact hypersensitivity via reducing HMGB1 release in keratinocytes.
    [Cell Death Discovery]

    Full ArticleGraphical Abstract

    Genomic Control of Inflammation in Experimental Atopic Dermatitis

    Researchers described a new topical treatment of atopic dermatitis by a nuclear transport checkpoint inhibitor, which targeted two nuclear transport shuttles, importin α5 and importin β1.
    [Scientific Reports]

    Full Article
    Explore this validated protocol for high-efficiency gene editing of Human Pluripotent Stem Cells using the ArciTect™ CRISPR-Cas9 System.
    REVIEWS

    The Basement Membrane in Epidermal Polarity, Stemness and Regeneration

    Scientists review key roles the basement membrane components play in preserving the stem cell pool, establishing cell polarity cues enabling asymmetric cell divisions, and regeneration of the epidermis during skin healing.
    [American Journal of Physiology-Cell Physiology]

    Abstract
    INDUSTRY AND POLICY NEWS

    OncoSec Announces Positive Clinical Data of the KEYNOTE-695 Trial Assessing TAVO-EP in Combination With Pembrolizumab (Keytruda®) in Patients with Advanced Melanoma Refractory to Anti-PD-1 Treatment

    This global, open-label single-arm trial evaluated TAVO™, OncoSec’s proprietary IL-12 encoding plasmid delivered by intratumoral electroporation, in combination with pembrolizumab in patients with unresectable or metastatic (Stage III/IV) melanoma.
    [OncoSec Medical, Inc.]

    Press Release

    University of California Academic Workers Go out on Strike to Demand Higher Wages

    Academic workers protest at the University of California, Berkeley, demanding higher salaries and better benefits from the state university system.
    [STAT News]

    Press Release
    FEATURED EVENT

    Stem Cells: Advances in the Application of Stem Cells and Their Role In Vivo

    February 5 – 8, 2023
    Keystone, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Cell Competition in Human In Vitro Systems

    University of Bristol – Bristol, United Kingdom

    Medical Science Liaison – Immunology

    AstraZeneca – Boston, Massachusetts, United States

    Lecturer – Cell and Developmental Biology

    Imperial College London – London, England, United Kingdom

    Medical Advisor – Dermatology

    Sanofi – Amsterdam, Netherlands

    Faculty Position – Regenerative Medicine

    University of Nebraska Medical Center – Omaha, Nebraska, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Dermal Cell News Twitter